John Lechleiter has been named the new CEO of Eli Lilly, reports the Wall Street Journal, and Derek Lowe thinks that's unusual (but still cool) because Lechleiter's a researcher who worked his way up from the bench to management. Lowe ponders why that doesn't happen more often in pharma. One reason is that a lot of scientists don't want to be managers.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.